Oral decitabine plus cedazuridine and venetoclax in patients with higher-risk myelodysplastic syndromes or chronic myelomonocytic leukaemia: a single-centre, phase 1/2 study

Álex Bataller, Guillermo Montalban‐Bravo, Alexandre Bazinet, Yesid Alvarado, Kelly S. Chien, Sangeetha Venugopal, Jo Ishizawa, Danielle Hammond, Mahesh Swaminathan, Koji Sasaki, Ghayas C. Issa, Nicholas J. Short, Lucia Masárová, Naval Daver, Tapan M. Kadia, Simona Colla, Wei Qiao, Xuelin Huang, Rashmi Kanagal‐Shamanna, Stephany Hendrickson, Farhad Ravandi, Elias Jabbour, Hagop M. Kantarjian, Guillermo Garcia‐Manero